Not yet reviewed — this article is pending editorial review by Lyrea.
Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
Pfbt
Fluorotropacocaine (pFBT) is a tropane derivative that acts as a local anaesthetic while also producing stimulant effects, with roughly 30% the stimulant potency of cocaine but comparable potency as a local anaesthetic. It was investigated as a radiolabelled agent for receptor binding studies but never adopted for that purpose. First detected by the EMCDDA in 2008, it has since circulated as a designer cocaine analogue sold in "bath salt" powders, typically combined with other stimulants such as caffeine, dimethocaine, desoxypipradrol, or substituted cathinones. It is considered habit-forming.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
Reported as a stimulant experience of markedly lower potency than cocaine, at roughly a third of its stimulant strength, combined with local anaesthetic properties of comparable strength to cocaine itself. Available material describes little beyond this stimulant and anaesthetic character.
Physical
Stimulation is the primary attested physical effect, described as substantially weaker than that of cocaine at equivalent quantities.
Pharmacology
Pharmacodynamics
Fluorotropacocaine is a tropane derivative that acts as a local anaesthetic while also producing stimulant effects. Its stimulant potency is reported to be around 30% that of cocaine, whereas its local anaesthetic potency is described as roughly equivalent to cocaine's.
Pharmacokinetics
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
History & Culture
Fluorotropacocaine was investigated as a potential radiolabelled agent for studying receptor binding, but it was not adopted for that purpose. Its principal use has instead been as a designer drug analogue of cocaine, first detected by the EMCDDA in 2008. It was subsequently sold as an ingredient in various "bath salt" powder products, typically combined with other stimulants such as caffeine, dimethocaine, desoxypipradrol, or substituted cathinone derivatives.
Legality
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Pfbt article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.